Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/0b49a43b-d959-4761-93b4-635544b6e4fe/
MVP
Medical Developments International LimitedSnapshot 2026-07-26 · 0.7w · Fresh
Strategy Eligibility
1 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
8.5%
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
15.0%ile
P/E
599.2×
P/S
1.4×
P/B
1.0×
FCF Yield
-0.027
EBITDA/EV
0.085
SH Yield
-0.159
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
86.00000000
/100 — 1=cheapest
VC2 (Trending Value)
91.00000000
/100
VC3 (Buyback)
90.00000000
/100
P/E of 599.2x is premium-priced — the market is paying up for expected growth. Negative FCF yield (-2.7%) — the business is currently cash-consumptive. VC2 score of 91.00000000/100 — expensive across all six composite measures.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
11.0%ile
ROE
0.002
ROA
0.001
Net Margin
0.002
Op Margin
-0.045
GPA
0.443
Current
4.54
F-Score
6/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.178
5yr Consist
No
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
7.0%ile
6M Return
0.0%
12M Return
-23.1%
12-1 Mom
-40.0%
Risk-Adj
-0.59
Vol 252d
67.7%
Vol 60d
143.1%
↑ Expanding
Max DD 12M
-47.6%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of -40% signals a downtrend — price is moving against you. Near-term vol (143%) is expanding vs long-term (68%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.04
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare
· 145 peers
Sector Value %ile
24.0%
Sector Quality %ile
16.4%
P/E z-score
7.40
P/B z-score
-0.52
Sector Avg OS
43.3%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
Factor Interactions
Volatility Expanding
60-day vol (143%) significantly exceeds 252-day (68%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
D
38.0% avg (6 factors)
Quality
D
34.8% avg (6 factors)
Momentum
F
13.8% avg (4 factors)
Risk
F
3.8% avg (1 factors)
Momentum is weak, suggesting the market isn't yet buying this thesis. Patience required. Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends8 snapshots
Factor Persistence8 snapshots
| Factor | Current | Streak | Trend | Spark |
|---|---|---|---|---|
| OS Composite | 0.040 | —1 | — | |
| Value %ile | 0.150 | —1 | — | |
| Quality %ile | 0.110 | —8 | — | |
| Momentum %ile | 0.070 | —8 | — | |
| F-Score | 6.000 | —0 | — | |
| Confidence | 0.403 | —0 | — | |
| Volatility | 0.677 | —8 | — |
Value Lens2021-07-27 → 2026-07-26
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
599.25
Price / Sales
1.44
Price / Book
1.02
FCF Yield
-2.7%
EBITDA / EV
8.5%
Sales Yield (1/P·S)
0.9648
Shareholder Yield
Div + net buyback / mktcap
-15.9%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
0.2%
Return on Assets
0.1%
Net Margin
0.2%
Operating Margin
-4.5%
Gross Profit / Assets
Novy-Marx GPA
44.3%
Current Ratio
4.54
External Financing
Net issuance — lower=better
0.166
MomentumPrice trend strength over different horizons
6M Return
0.0%
12M Return
-23.1%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
-40.0%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
-0.59
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
17.8%
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
6
Buyback Yield
-15.9%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
86
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
91
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
90
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity